Cell & Gene Therapy Commercial Insight – September 2019

Published: 30 October 2019
Commercial Insights
Mark Curtis,
Mark Curtis
Financial Portfolio Manager, Emerging Technologies at Lonza
Richard Philipson
Richard Philipson

Providing a critical overview of the sector’s commercial developments – M&As, licensing agreements & collaborations, financial results, IPOs and clinical/regulatory updates, with commentary from our Expert Contributors.

Read now